Skip to main content
Top
Published in: Vascular Cell 1/2012

Open Access 01-12-2012 | Editorial

“Large eaters” meet blood vessels: a new thematic series on macrophages and angiogenesis

Author: Jan Kitajewski

Published in: Vascular Cell | Issue 1/2012

Login to get access

Abstract

Vascular Cell has launched a new series on macrophages and angiogenesis, a quickly evolving field critical to blood and lymphatic vessels during development, inflammation and tumorigenesis.
Literature
1.
go back to reference Harvey NL, Gordon EJ: Deciphering the roles of macrophages in developmental and inflammation stimulated lymphangiogenesis. Vascular cell. 2012, 4 (1): 15-10.1186/2045-824X-4-15.PubMedCentralCrossRefPubMed Harvey NL, Gordon EJ: Deciphering the roles of macrophages in developmental and inflammation stimulated lymphangiogenesis. Vascular cell. 2012, 4 (1): 15-10.1186/2045-824X-4-15.PubMedCentralCrossRefPubMed
4.
go back to reference Dvorak HF: Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986, 315 (26): 1650-1659. 10.1056/NEJM198612253152606.CrossRefPubMed Dvorak HF: Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986, 315 (26): 1650-1659. 10.1056/NEJM198612253152606.CrossRefPubMed
Metadata
Title
“Large eaters” meet blood vessels: a new thematic series on macrophages and angiogenesis
Author
Jan Kitajewski
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Vascular Cell / Issue 1/2012
Electronic ISSN: 2045-824X
DOI
https://doi.org/10.1186/2045-824X-4-17

Other articles of this Issue 1/2012

Vascular Cell 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine